We are live on ! Find out more
WCM

Wildcat Capital Management Portfolio holdings

AUM $229M
1-Year Est. Return 132.65%
This Fund
S&P 500
This Quarter Est. Return
-1.04%
1 Year Est. Return
+132.65%
3 Year Est. Return
+125.67%
5 Year Est. Return
+54.1%
10 Year Est. Return
+1,929.91%
AUM
$152M
AUM Growth
+$22.5M
Cap. Flow
+$44.4M
Cap. Flow %
29.2%
Top 10 Hldgs %
94.48%
Holding
25
New
6
Increased
2
Reduced
1
Closed
5

Top Buys

Rank Stock Value
1
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
+$19.2M
2
URGN icon
UroGen Pharma
URGN
+$10.7M
3
BKNG icon
Booking.com
BKNG
+$8.55M
4
META icon
Meta Platforms (Facebook)
META
+$2.85M
5
SBR
Sabine Royalty Trust
SBR
+$1.73M

Top Sells

Rank Stock Value
1
CSGP icon
CoStar Group
CSGP
+$552K
2
APPF icon
AppFolio
APPF
+$468K
3
GDX icon
VanEck Gold Miners ETF
GDX
+$278K

Sector Composition

Rank Sector Weight
1 Real Estate 30.14%
2 Healthcare 23.37%
3 Energy 10.87%
4 Financials 8.37%
5 Consumer Discretionary 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSGP icon
1
CoStar Group
CSGP
$11.7B
$45.9M 30.14%
1,359,220
-15,100
-1% -$552K
URGN icon
2
UroGen Pharma
URGN
$1.86B
$26.4M 17.34%
612,494
+237,015
+63% +$10.7M
VXX
3
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$24.4M 16.03%
+520,000
New +$19.2M
LPLA icon
4
LPL Financial
LPLA
$28.3B
$12.7M 8.37%
208,401
– –
SBR
5
Sabine Royalty Trust
SBR
$1.06B
$12.4M 8.16%
335,564
+45,601
+16% +$1.73M
BKNG icon
6
Booking.com
BKNG
$149B
$8.03M 5.28%
+116,525
New +$8.55M
EDIT icon
7
Editas Medicine
EDIT
$396M
$4.22M 2.78%
185,668
– –
MGY icon
8
Magnolia Oil & Gas
MGY
$6.09B
$4.13M 2.71%
368,000
– –
GRTS
9
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$3M 1.98%
194,500
– –
META icon
10
Meta Platforms (Facebook)
META
$1.42T
$2.58M 1.7%
+19,685
New +$2.85M
PLYA
11
DELISTED
Playa Hotels & Resorts
PLYA
$2.16M 1.42%
300,000
– –
COUP
12
DELISTED
Coupa Software Incorporated
COUP
$1.35M 0.88%
21,408
– –
JD icon
13
JD.com
JD
$44.6B
$1.13M 0.74%
+53,882
New +$1.21M
SRNE
14
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$998K 0.66%
415,765
– –
SNNA
15
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$686K 0.45%
295,613
– –
IBRX icon
16
ImmunityBio
IBRX
$7.51B
$645K 0.42%
556,453
– –
ENTX icon
17
Entera Bio
ENTX
$147M
$620K 0.41%
+203,190
New +$1.01M
MSFT icon
18
Microsoft
MSFT
$3.45T
$452K 0.3%
+4,449
New +$477K
AYX
19
DELISTED
Alteryx Inc
AYX
$260K 0.17%
4,376
– –
NH
20
DELISTED
NantHealth, Inc
NH
$109K 0.07%
13,358
– –
APPF icon
21
AppFolio
APPF
$6.38B
– –
-5,972
Closed -$468K
GDX icon
22
VanEck Gold Miners ETF
GDX
$22.7B
– –
-15,000
Closed -$278K
GDX icon
23
PUT
VanEck Gold Miners ETF
GDX
$22.7B
– –
-688,800
Closed -$7K
OEF icon
24
CALL
iShares S&P 100 ETF
OEF
$20.1B
– –
-271,700
Closed -$1K
VXX
25
PUT
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
– –
-116,100
Closed -$2K

Similar funds

AFO
Allie Family Office Miami, Florida $228M AUM 17.95% 1-Year Est. Return
CNHF
Conrad N. Hilton Foundation Agoura Hills, California $228M AUM 15.24% 1-Year Est. Return
GCM
GeoSphere Capital Management Miami Beach, Florida $229M AUM 157.16% 1-Year Est. Return
CM
Cosmic Management West Hollywood, California $229M AUM
CSIA
Carl Stuart Investment Advisor Austin, Texas $229M AUM 28.92% 1-Year Est. Return
AF
Abound Financial Granite Bay, California $229M AUM 17.03% 1-Year Est. Return
NIA
NBZ Investment Advisors Knoxville, Tennessee $229M AUM 17.28% 1-Year Est. Return
HFA
Hippocratic Financial Advisors Westlake Village, California $228M AUM 11.95% 1-Year Est. Return

Wildcat Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Wildcat Capital Management held 25 positions worth $152M, up 17% from $130M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Wildcat Capital Management deployed $44.4M of net new capital in Q4 2018, opening 6 new positions and adding to 2 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 520,000 shares worth $24.4M.

By sector, the portfolio is most concentrated in Real Estate at 30% of assets, down from 45% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was CoStar Group, an estimated $552K trimmed.

  • Wildcat Capital Management's largest Q4 2018 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 520,000 shares worth $24.4M.
  • Wildcat Capital Management added most to UroGen Pharma in Q4 2018, an estimated $10.7M increase.
  • Wildcat Capital Management's biggest Q4 2018 reduction was CoStar Group, cutting an estimated $552K.
  • Wildcat Capital Management fully exited AppFolio in Q4 2018, selling an estimated $468K.
  • Wildcat Capital Management's ten largest holdings make up 94% of its $152M portfolio in Q4 2018.
  • Wildcat Capital Management opened 6 new positions and closed 5 in Q4 2018.
  • Wildcat Capital Management's portfolio value rose 17% quarter-over-quarter to $152M.

Based on Wildcat Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.